Get started
Innocan Pharma Corp.Innocan Pharma Corp.Innocan Pharma Corp.

Innocan Pharma Corp.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Seasonals

INNPD chart


Full chart

Key stats


Market capitalization
‪41.54 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.36 USD
Net income (FY)
‪−1.75 M‬ USD
Revenue (FY)
‪28.02 M‬ USD
Shares float
‪3.44 M‬
Beta (1Y)
0.22

About InnoCan Pharma Corporation


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Iris Or Gabi Bincovich
Website
innocanpharma.com
Headquarters
Calgary
Founded
2018
ISIN
CA45783P5085
FIGI
BBG00YB9B2M2
InnoCan Pharma Corp. operates as a pharmaceutical tech company. It operates through the Online Sales and Other Operations segments. The Online Sales segment engages in the development of non-CBD personal care and beauty products in the United States for online platforms such as Amazon, and other e-commerce retail sales. The Other Operations segment involves in the development of several drug delivery platforms, combining cannabinoids with other pharmaceutical ingredients as well as the development and sale of CBD-integrated topical products. The company was founded in October 2017 and is headquartered in Alberta, Canada.

Check out other big names from the same industry as INNPD.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

INNPD news



Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Innocan Pharma Corp. stocks are traded under the ticker INNPD.
INNPD reached its all-time high on Sep 16, 2021 with the price of 82.59 USD, and its all-time low was 5.20 USD and was reached on Jun 20, 2025. View more price dynamics on INNPD chart.
See other stocks reaching their highest and lowest prices.
INNPD stock is 0.20% volatile and has beta coefficient of 0.22. Track Innocan Pharma Corp. stock price on the chart and check out the list of the most volatile stocks — is Innocan Pharma Corp. there?
Yes, you can track Innocan Pharma Corp. financials in yearly and quarterly reports right on TradingView.
INNPD net income for the last quarter is ‪−599.72 K‬ USD, while the quarter before that showed ‪−580.24 K‬ USD of net income which accounts for −3.36% change. Track more Innocan Pharma Corp. financial stats to get the full picture.
No, INNPD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Innocan Pharma Corp. EBITDA is ‪361.43 K‬ USD, and current EBITDA margin is −4.12%. See more stats in Innocan Pharma Corp. financial statements.
Like other stocks, INNPD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Innocan Pharma Corp. stock right from TradingView charts — choose your broker and connect to your account.